Lab
Fairview Health Services
Fairview Health Services was paid $1.12M by Medicaid between Jan 2018 and Oct 2024, across 64 billing codes. Its largest line is 87651, Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe — 16% of everything it billed.
33Billing provider infoFAIRVIEW HEALTH SERVICES
MINNEAPOLIS, MN 55454
MINNEAPOLIS, MN 55454
33aNPI1316008212assigned 12/13/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.12M
24GClaims68,042
24DCodes billed64
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Minnesota
Rank by total paid#17 of 69
Median peer was paid$48K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RING, MAUREEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,807 | $117K | |
| 2019 | 15,407 | $387K | |
| 2020 | 11,653 | $261K | |
| 2021 | 9,605 | $182K | |
| 2022 | 5,215 | $73K | |
| 2023 | 6,165 | $58K | |
| 2024incomplete | 3,190 | $39K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 16% | 7,188 | 6,994 | $181K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13% | 3,726 | 3,580 | $142K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 11% | 3,749 | 3,604 | $119K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.5% | 2,286 | 1,247 | $84K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.5% | 2,781 | 2,732 | $73K |
| 80061 | Lipid panel | 5.8% | 5,224 | 5,118 | $65K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.4% | 4,035 | 3,925 | $60K |
| 80053 | Comprehensive metabolic panel | 5.2% | 5,472 | 5,279 | $58K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.3% | 1,868 | 1,840 | $37K |
| 86780 | 2.3% | 1,977 | 1,899 | $26K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.1% | 2,761 | 2,613 | $23K |
| 86803 | 1.9% | 1,467 | 1,426 | $21K |
52 more codes
| 36415 | Collection of venous blood by venipuncture | 1.8% | 5,208 | $20K |
| 86481 | 1.7% | 229 | $19K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.6% | 1,015 | $18K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 1.4% | 2,125 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 2,002 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.2% | 1,573 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 1,529 | $12K |
| 87340 | <1% | 1,134 | $11K | |
| 86706 | <1% | 989 | $10K | |
| 87186 | <1% | 1,220 | $9K | |
| 87088 | <1% | 1,204 | $9K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 390 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 214 | $6K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 802 | $6K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 220 | $6K |
| 86480 | <1% | 146 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 122 | $5K |
| 82043 | <1% | 765 | $4K | |
| 83655 | <1% | 439 | $4K | |
| 80076 | <1% | 428 | $4K | |
| 80069 | <1% | 362 | $4K | |
| 82728 | <1% | 304 | $3K | |
| 87081 | <1% | 577 | $3K | |
| 84439 | <1% | 399 | $3K | |
| 85004 | <1% | 369 | $2K | |
| 85027 | <1% | 442 | $2K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 55 | $1K |
| 87338 | <1% | 136 | $1K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 61 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 164 | $849.17 |
| 82607 | <1% | 85 | $839.85 | |
| 87209 | <1% | 22 | $743.16 | |
| 84403 | <1% | 17 | $600.47 | |
| 86708 | <1% | 44 | $585.50 | |
| 83970 | <1% | 12 | $542.02 | |
| 87522 | Neg quan hep c or qual rna | <1% | 13 | $491.55 |
| 86900 | <1% | 12 | $429.21 | |
| 86709 | <1% | 29 | $384.55 | |
| 87177 | <1% | 22 | $371.58 | |
| 86140 | <1% | 42 | $358.81 | |
| 80197 | <1% | 19 | $314.07 | |
| 84156 | <1% | 70 | $258.60 | |
| 86787 | <1% | 12 | $229.21 | |
| 86682 | <1% | 13 | $223.25 | |
| 85610 | <1% | 329 | $222.93 | |
| 86790 | <1% | 25 | $213.44 | |
| 83550 | <1% | 25 | $204.06 | |
| 82274 | <1% | 42 | $193.92 | |
| 83540 | <1% | 13 | $76.98 | |
| 82746 | <1% | 13 | $73.60 | |
| 0065U | <1% | 14 | $26.96 | |
| 87653 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRING, MAUREEN (SYS DIR GOVT REIMB & NETWK REL)
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.